Outcomes and prognostic factors in thyroid cancer patients with cranial metastases: A retrospective cohort study of 4,683 patients

被引:12
|
作者
Hong, Yi-Wen [1 ]
Lin, Jen-Der [2 ]
Yu, Ming-Chin [1 ]
Hsu, Chih-Chieh [1 ]
Lin, Yann-Sheng [1 ]
机构
[1] Chang Gung Univ, Chang Gung Mem Hosp, Linkou Branch, Dept Surg, 5 Fuxing St, Taoyuan 333, Taiwan
[2] Chang Gung Univ, Chang Gung Mem Hosp, Linkou Branch, Div Endocrinol & Metab,Dept Internal Med, 5 Fuxing St, Taoyuan 333, Taiwan
关键词
Thyroid cancer; Brain metastasis; Skull metastasis; Radioiodine; Surgery; BRAIN METASTASES; FOLLOW-UP; DISTANT METASTASIS; SKULL METASTASIS; CARCINOMA; PAPILLARY; RADIOIODINE; MANAGEMENT;
D O I
10.1016/j.ijsu.2018.06.001
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Cranial metastasis of thyroid cancer is rare. The aim of this study was to analyse the clinical characteristics, treatments and outcomes of thyroid cancer patients with cranial metastasis and to identify the associated prognostic factors. Materials and methods: Between January 1977 and August 2017, a total of 4683 patients were histologically confirmed to have thyroid cancer. Among them, 25 patients (0.53%) were identified as having cranial metastases, and their medical records were reviewed. The Kaplan-Meier method with a log-rank test was performed with cancer-specific survival as the main outcome. Cox regression analysis was used to examine the potential prognostic factors influencing patient survival. Results: Of the 25 patients, 21 were female, and 4 were male. The median age at the time of diagnosis of cranial metastasis was 63 years. Sixteen patients had metastases to the brain, and nine patients had metastases involving the skull only. Papillary carcinoma and follicular carcinoma accounted for 84.0% of cases. Twenty-four cases (96.0%) had extracranial metastases at the time of diagnosis of cranial metastases. Twenty patients received surgery, and 4 patients received palliative radiotherapy. One patient received supportive care only. The median cancer-specific survival after the diagnosis of cranial metastases was 27 months. According to the Kaplan-Meier test, 3 factors had a significant impact on survival, the metastatic site, histological types and surgical resection. According to the Cox regression analysis, skull metastases (HR: 0.274, 95% CI: 0.083-0.904, p = 0.033) and surgical resection (HR: 0.134, 95% CI: 0.019-0.929, p = 0.042) were identified as independent prognostic factors for a better outcome. Conclusions: Surgical resection is the mainstay therapy for thyroid cancer patients with cranial metastasis. Cranial metastases involving the skull only are associated with a better outcome.
引用
收藏
页码:182 / 187
页数:6
相关论文
共 50 条
  • [21] The risk and prognostic factors for liver metastases in esophageal cancer patients: A large-cohort based study
    Luo, Peng
    Wei, Xiufeng
    Liu, Chen
    Chen, Xiankai
    Yang, Yafan
    Zhang, Ruixiang
    Kang, Xiaozheng
    Qin, Jianjun
    Qi, Xiuzhu
    Li, Yin
    THORACIC CANCER, 2022, 13 (21) : 2960 - 2969
  • [22] Clinical outcomes of a cohort of patients with central nervous system metastases from thyroid cancer
    Simoes-Pereira, Joana
    Macedo, Daniel
    Bugalho, Maria Joao
    ENDOCRINE CONNECTIONS, 2016, 5 (06): : 82 - 88
  • [23] Brain metastases in gynecologic cancer in the modern era: a retrospective cohort study evaluating treatment outcomes, prognostic factors, and overall survival
    Cooke, Carly
    Babadagli, Ege
    Wilson, Hillary
    Nair, Vimoj
    Samant, Rajiv
    Le, Tien
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (SUPPL_3) : A279 - A279
  • [24] A retrospective cohort study of patients diagnosed of thyroid cancer in the southwest Madrid area. Predictive factors in differentiated thyroid cancer
    Donnay Candil, Sergio
    Gorgojo Martinez, Juan Jose
    Requejo Salinas, Helena
    Lopez Hernandez, Elena
    Almodovar Ruiz, Francisca
    Mitjavila Casanovas, Mercedes
    Pinedo Moraleda, Fernando
    ENDOCRINOLOGIA Y NUTRICION, 2013, 60 (02): : 61 - 69
  • [25] Analysis of prognostic factors of thyroid cancers in patients with distant metastases
    Bence-Zigman, Z
    Dodig, D
    Zigman, T
    Zarkovic, T
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2004, 31 : S436 - S436
  • [26] Prognostic factors and clinical outcomes in patients with vulvar cancer: a 15-year retrospective study
    Rahong, Tharinee
    Achariyapota, Vuthinun
    Sitthinamsuwan, Panitta
    Hanamornroongruang, Suchanan
    Khemworapong, Khemanat
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023, 33 (SUPPL_4) : A245 - A246
  • [27] Long-term outcomes and prognostic factors in papillary thyroid microcarcinoma patients with distant metastases
    Weng, Huai-Yu
    Yan, Ting
    Qiu, Wang-Wang
    Xi, Chuang
    Hou, Li-Ying
    Yang, Zhi-Li
    Qiu, Zhong-Ling
    ENDOCRINE, 2022, 75 (02) : 495 - 507
  • [28] Long-term outcomes and prognostic factors in papillary thyroid microcarcinoma patients with distant metastases
    Huai-Yu Weng
    Ting Yan
    Wang-Wang Qiu
    Chuang Xi
    Li-Ying Hou
    Zhi-Li Yang
    Zhong-Ling Qiu
    Endocrine, 2022, 75 : 495 - 507
  • [29] LONG-TERM OUTCOMES AND PROGNOSTIC FACTORS IN PATIENTS WITH DIFFERENTIATED THYROID CARCINOMA AND BONE METASTASES
    Slook, Omer
    Levy, Sigal
    Slutzky-Shraga, Ilana
    Tsvetov, Gloria
    Robenshtok, Eyal
    Shimon, Ilan
    Benbassat, Carlos
    Hirsch, Dania
    ENDOCRINE PRACTICE, 2019, 25 (05) : 427 - 437
  • [30] Treatment outcomes and prognostic factors for patients with brain metastases from breast cancer of each subtype: a multicenter retrospective analysis
    Niikura, Naoki
    Hayashi, Naoki
    Masuda, Norikazu
    Takashima, Seiki
    Nakamura, Rikiya
    Watanabe, Ken-ichi
    Kanbayashi, Chizuko
    Ishida, Mayumi
    Hozumi, Yasuo
    Tsuneizumi, Michiko
    Kondo, Naoto
    Naito, Yoichi
    Honda, Yayoi
    Matsui, Akira
    Fujisawa, Tomomi
    Oshitanai, Risa
    Yasojima, Hiroyuki
    Tokuda, Yutaka
    Saji, Shigehira
    Iwata, Hiroji
    BREAST CANCER RESEARCH AND TREATMENT, 2014, 147 (01) : 103 - 112